Importantly, while neutrophils express high affinity receptors for both IgG and IgA, IgA appears more efficient than IgG to kill tumor cells, as shown with therapeutic antibodies in vitro and in vivo [126,127,128]. The gene discussed is CD79A; the disease is neoplasm.